Is HOOD a buy, hold, or sell?
HOOD carries a valuation grade of Buy. The trailing P/E of 41.9 sits 199% above the Financials sector median of 14.0x — a premium that demands sustained earnings delivery. Our discounted cash flow model produces an intrinsic range of $44–$124 — implying a -3% margin of safety at the current price of $86.36. The width of the DCF range reflects genuine uncertainty in the terminal growth rate assumption: the correct framework is a probability-weighted distribution over scenarios, not a single point estimate. See the DCF valuation framework for full methodology.
With a 12% beat rate on recent quarters, earnings predictability has been mixed. The most recent quarter missed by a 2.0% earnings surprise. Analyst estimate revisions are trending upward.
What are HOOD's key risk factors?
With a beta of 2.35, HOOD exhibits a highly aggressive risk profile relative to the broad market. The 95th-percentile CVaR of -41.2% on a one-month horizon should inform position sizing directly: at a 10% portfolio weight, this tail event contributes approximately 4.1% of total portfolio loss in the worst 5% of months. Net margins of 41.1% are significantly above the Financials sector average of 28%, reflecting durable pricing power. Return on equity of 21.5% suggests solid capital efficiency. Leverage is moderate with debt-to-equity at 140%.
Implied volatility of 3.0% is below realized volatility of 78.8%, potentially making options relatively cheap. Insiders have been net sellers to the tune of $1475.7M recently. While routine dispositions are common, the magnitude bears watching. Short interest is low at 4.4% of float, suggesting limited bearish conviction.
How does HOOD fit in a diversified portfolio?
At typical HENRY portfolio weights — 10–20% of the equity allocation — HOOD carries a beta of 2.35, meaning it amplifies broad market moves proportionally. The appropriate weight is not a function of conviction alone, but of the full covariance structure across all buyings. See the Ledoit-Wolf covariance framework for the methodology behind these calculations.
Among closely correlated names, HOOD shows the strongest co-movement with COIN (0.73), IBKR (0.67), SOFI (0.64). Investors seeking diversification should note these correlation dynamics when constructing multi-asset portfolios. With the top peer correlation at 0.73, adding HOOD to a portfolio that already buys these names provides limited marginal diversification benefit — particularly during stress events when correlations converge toward 1.0.
True portfolio risk is a function of the full covariance structure across all buyings — not individual stock metrics. The Portfolio Health Check quantifies this at the portfolio level: it surfaces hidden concentration, marginal CVaR contributions, and the degree to which your overall allocation deviates from an optimal risk-adjusted mandate. The HOOD analysis here is a single node in that larger structure.
For the full prediction markets conviction thesis — covering HOOD’s position in the $51B→$1T distribution race, revenue model, regulatory risk framework (9th Circuit, S. 4469), and CFA-grade conviction rating — see: Prediction Markets 2026 — HOOD, COIN & IBKR Win the $1T Distribution Race →
